U. E. Udodong et al. / Tetrahedron 59 (2003) 2667–2672
2671
Chem. 1992, 35, 194. (b) Iwamoto, T.; Fujie, A.; Sakamoto,
K.; Tsurumi, Y.; Shigematsu, N.; Yamashita, M.; Hashimoto,
S.; Okuhara, M.; Kohsaka, M. J. Antibiot. 1994, 47, 1084.
(c) Fromtling, R. A. Drugs Future 1994, 19, 933.
(d) Hammond, M. L. Chemical and Structure–Activity
Studies of the Echinocandin Lipopeptides. In Cutaneous
Antifungal Agents; Rippon, J. W., Fromtling, R. A., Eds.;
Marcel Dekker: New York, 1993; pp 395–420.
4.35 mmol) in DMF (13 mL) was added dropwise to a
solution of t-BuOLi (95% pure, 0.43 g, 5.13 mmol) in DMF
(13 mL). The mixture was stirred at room temperature for
20–30 min or until a homogeneous solution (dark brown)
resulted. Upon cooling to 08C, the dimethyldiphosphonate 7
(97.7% pure, 2.69 g, 5.13 mmol) in THF (26 mL) was added
dropwise (0.4 mL/min). After the addition, the reaction was
stirred at 08C and monitored by HPLC until most of 1c was
consumed (1–2% remained). The mixture was quenched
with 2 equiv. of acetic acid (based on amount of base used)
and stirred at 08C for 10–15 min. The mixture was poured
into CH3CN (133 mL) with stirring at room temperature.
The reaction flask was rinsed with another 100 mL of
CH3CN. The precipitate was collected by filtration and
dried under vacuum. The crude product was dissolved in
methanol (10.5 mL) and the solution poured into water
(133 mL) to re-precipitate the product. The precipitate was
stirred vigorously for 10 min and filtered to obtain 4.6 g
(84% yield, corrected for 87.7% HPLC potency) of 1d. An
analytical sample was purified by silica gel chromatography
(85:15 CH2Cl2/MeOH). Rf 0.43 (90:10 CH2Cl2/MeOH). IR
4. Udodong, U. E.; Turner, W. W.; Astleford, B. A.; Brown, F.,
Jr.; Clayton, M. T.; Dunlap, S. E.; Frank, S. A.; Grutsch, J. L.;
LaGrandeur, L. M.; Verral, D. E.; Werner, J. A. Tetrahedron
Lett. 1998, 39, 6115.
5. Rodriquez, M. J.; Vasudevan, V.; Jamison, J. A.; Borromeo,
P. S.; Turner, W. W. Bioorg. Med. Chem. Lett. 1999, 9, 1863.
6. (a) Dorman, M. A.; Noble, S. A.; McBride, L. J.; Caruthers,
M. H. Tetrahedron 1984, 40, 95. (b) Worms, K. H.; Schmidt-
Dunker, M. Organo Phosphorus Compounds; Kosolapoff,
G. M., Maier, L., Eds.; Wiley: New York, 1973; Vol. 7, p 1.
(c) Clivo, P.; Fourrey, J.-L. J. Org. Chem. 1994, 59, 7273.
7. See, for example: (a) Campbell, D. A.; Bermak, J. C. J. Org.
Chem. 1994, 59, 658. (b) Saady, M.; Lebeau, L.; Mioskowski,
C. Tetrahedron Lett. 1995, 36, 2239. (c) Willems, H. A. M.;
Veenemen, G. H.; Westerduin, P. Tetrahedron Lett. 1992, 33,
2075. (d) Valentijn, A. R. P. M.; van der Marel, G. A.; Cohen,
L. H.; van Boom, J. H. Synlett 1991, 663. (e) Tawfik, D. S.;
Eshhar, Z.; Bentolila, A.; Green, B. S. Synthesis 1993, 968.
(f) Saady, M.; Lebeau, L.; Mioskowski, C. Tetrahedron Lett.
1995, 36, 4785. (g) Wozniak, L. A.; Wieczorek, M.; Pyzowski,
J.; Majzner, W.; Stec, W. J. J. Org. Chem. 1998, 63, 5395.
(h) Wozniak, L. A.; Chworos, A.; Pyzowski, J.; Stec, W. J.
J. Org. Chem. 1998, 63, 9109. (i) Lesnikowski, Z. J.;
Zabawaska, D.; Jaworska-Maslanka, M. M.; Schinazi, R. F.;
Stec, W. J. New J. Chem. 1994, 18, 1197.
(CHCl3) 1639, 1609, 1529 cm21. MS (FABþ) m/z 1356. 31
NMR (DMSO-d6) d 25.68.
P
4.1.7. Preparation of dideoxy ECB methylphosphonate
monoester 1e. A solution of 1d (97% pure, 100 mg,
0.08 mmol) in 90:10 THF/DMF (1.5 mL) was treated with
triethylamine (0.03 mL, 0.22 mmol). The solution was
hydrogenated for 3 h over 10% Pd–C (50 mg) at 1 atm of
hydrogen. The catalyst was removed by filtration through a
bed of celite and rinsed with THF (10 mL). The filtrate was
concentrated at reduced pressure to remove THF. The
residue was triturated with MeCN (10 mL) to give a white
precipitate. The solid was filtered and rinsed twice with
Et2O (3 mL) to obtain 65 mg (74%) of 1e. An analytical
sample was purified by HPLC chromatography. IR (KBr)
1634, 1507, 1436 cm21. HRMS (FABþ) m/z calcd for
C59H77N7O17P: 1186.5114. Found: 1186.5139. 31P NMR
(DMSO-d6) d 20.93.
8. Compound 8 is only observed by HPLC as monoester 6
following an aqueous quench. Selective formation of the
desired phosphonate monoester has been reported using
phenylphosphonic dichloride. With alkyl phosphonic
dichlorides, variable success has been reported. See:
(a) Zhao, K.; Landry, D. W. Tetrahedron 1993, 49, 363.
Entries 8 and 9 in Table 1. (b) Yang, G.; Zhao, K.; Landy,
D. W. Tetrahedron Lett. 1998, 39, 2449. Entries 3 and 4 in
Table 1. (c) Mlodnosky, K. L.; Holmes, H. M.; Lam, V. Q.;
Berkman, C. E. Tetrahedron Lett. 1997, 38, 8803.
Acknowledgements
9. Conversion of phosphonic chlorides to the diphosphonate with
water is known. In our process, this results in a mixture of
diphosphonate 7, diester 4 and phosphonate monoester 6. Due
to instability of 7, this mixture cannot be purified. See: Ohms,
G.; Grossmann, G.; Schwab, B.; Schiefer, H. Phosphorus
Sulfur Silicon Relat. Elem. 1992, 68, 77.
We thank the Molecular Structure Division of Eli Lilly and
Company for spectral data, Doug Dorman for spectral
characterization of 1c, 1d and 1e, Craig Mann for HPLC
purification of ECB compounds and Bill Turner for helpful
discussions.
10. The process in path b is a significant improvement over path a
and avoids the formation of 4-bromobenzyl iodide, a strong
lachrymator. See: Zervas, L.; Kilaris, I. J. Am. Chem. Soc.
1955, 77, 5354.
References
11. Khorana, H. G.; Todd, A. R. J. Am. Chem. Soc. 1953, 2257.
12. Diphosphonate 7 is stable to storage in a freezer for at least
four months.
1. Debono, M.; Turner, W. W.; LaGrandeur, L.; Burkhardt, F. J.;
Nissen, J. S.; Nichols, K. K.; Rodriguez, M. J.; Zweifel, M. J.;
Zeckner, D. J.; Gordee, R. S.; Tang, J.; Parr, T. R., Jr. J. Med.
Chem. 1995, 38, 3271.
13. Initial studies of the phosphorylation of 1a showed that lithium
bases gave the fastest reaction, the order of reactivity being
Liþ.Naþ.Kþ. See Ref. 4.
2. Turner, W. W.; Rodriguez, M. J. Curr. Pharm. Des. 1996, 2,
209, and references therein.
3. (a) Balkovec, J. M.; Black, R. M.; Hammond, M. L.; Heck,
J. V.; Zambias, R. A.; Abruzzo, G.; Bartizal, K.; Kopp, H.;
Trainor, C.; Schwartz, R. E.; McFadden, D. C.; Nollstadt,
K. H.; Pittarelli, L. A.; Powles, M. A.; Schmatz, D. M. J. Med.
14. Compound 1d is a mixture of diastereomers, but the isomers
are so similar that only one set of peaks is observed by 1H, 13
and 31P NMR spectroscopy.
15. Although toxicity data for the phosphorus compounds
C